What are the Historical Developments and Current Growth Metrics of the Clot Management Devices Market?
The clot management devices market has seen considerable growth due to a variety of factors.
• The clot management devices market has expanded significantly in recent years. It will grow from $1.72 billion in 2024 to $1.83 billion in 2025, at a compound annual growth rate (CAGR) of 6.4%.
The market's growth can be attributed to the aging population, regulatory approvals, clinical trials, increased awareness and screening programs, and the rising prevalence of cardiovascular diseases.
What is the Forecasted Market Size and CAGR for the Clot Management Devices Market?
The clot management devices market is expected to maintain its strong growth trajectory in upcoming years.
• The clot management devices market is expected to grow to $2.32 billion by 2029 at a 6.0% CAGR. Growth is attributed to rising healthcare expenditure, personalized medicine, and regulatory policies. Major trends include technological innovations, thrombectomy tool advancements, and AI and machine learning integration.
What Key Factors and Trends Are Driving The Growth Clot Management Devices Market?
The increasing demand for hospitals is expected to spur the growth of the clot management device market. Hospitals, which provide medical care and treatment, are growing due to factors like aging populations, urbanization, and medical tourism. Clot management devices are vital in treating conditions such as deep vein thrombosis and pulmonary embolism, offering effective, minimally invasive solutions. In May 2024, the American Health Care Association reported that the number of hospitals in the U.S. increased from 5,129 in 2022 to 6,120. This growing demand for hospitals is expected to drive the clot management device market.
What Are The Market Segments In The Clot Management Devices Market?
The clot management devices market covered in this report is segmented –
1) By Product Type: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) devices, Inferior vena cava filters (IVCF)
2) By Percutaneous Thrombectomy Devices Type Outlook: Aspiration Thrombectomy Devices, Percutaneous Mechanical Thrombectomy Device
3) By End User: Diagnostic centers, Hospitals
Subsegments:
1) By Neurovascular Embolectomy Devices: Aspiration Embolectomy Devices, Mechanical Embolectomy Devices, Embolectomy Balloon Catheters
2) By Embolectomy Balloon Catheters: High-Pressure Balloon Catheters, Low-Pressure Balloon Catheters
3) By Percutaneous Thrombectomy Devices: Rotational Thrombectomy Devices, Aspiration Thrombectomy Devices
4) By Catheter-Directed Thrombolysis (CDT) Devices: Infusion Catheters, Guidewires For CDT
5) By Inferior Vena Cava Filters (IVCF): Permanent IVC Filters, Retrievable IVC Filters
Pre-Book The Clot Management Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Clot Management Devices Market?
Companies in the clot management device market are introducing cutting-edge technologies like computer-assisted vacuum thrombectomy (CAVT) systems to offer advanced features. CAVT systems are used to treat blood clots in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical firm, launched the Lightning Flash 2.0. This advanced clot aspiration and vacuum thrombectomy technology rapidly removes blood clots, integrating AI and advanced engineering for better performance and patient outcomes. The system features enhanced imaging and suction capabilities for precise clot removal.
Who Are the Key Players In The Clot Management Devices Market?
Major companies operating in the clot management devices market are:
• Cardinal Health Inc.
• Bayer AG
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• Becton Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• DePuy Synthes Inc.
• Terumo Corporation
• Edwards Lifesciences Corporation
• Acandis GmbH & Co. KG
• Cook Medical
• Merit Medical Systems Inc.
• Applied Medical Resources Corporation
• Penumbra Inc.
• MicroVention Inc.
• Inari Medical Inc.
• AngioDynamics Inc.
• Argon Medical Devices Inc.
• LeMaitre Vascular Inc.
• iVascular S.L.U.
• Straub Medical AG
• Rapid Medical
What Are The Regional Insights Into The Clot Management Devices Market?
North America was the largest region in the clot management devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
